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A B S T R A C T
Background: In children with cerebral palsy (CP), overactivity of the peroneus longus (PL) muscle is a
major contributor to pes planovalgus. This retrospective study assessed whether abobotulinumtoxinA
injections into a PL showing premature activity on electromyography (EMG) clinically improved foot
morphology in children with CP.
Methods: Study participants were < 6 years old, had a diagnosis of CP, good functional abilities (Gross
Motor Function Classiﬁcation System level 1 or 2), equinovalgus (initial contact with the hallux or head
of the ﬁrst metatarsal) and overactive PL on EMG. The fore-, mid- and hindfoot were evaluated clinically
and radiologically before and after injection of abobotulinumtoxinA (6–7 U/kg) into the PL. Radiological
data were compared with reference values for children without pes planovalgus.
Results: In total, 16 children (8 males; 10 hemiplegia, 6 diplegia; mean age: 3.2  1.5 years) received
treatment. Mean pre-and post-treatment angles in clinical assessment of dorsiﬂexion of the talocrural
articulation did not differ with both knees ﬂexed (24.4  7.5 vs. 22.2  8.0 degrees; P = 0.19) or extended
(17.2  8.0 vs. 16.6  6.8 degrees; P = 0.36). Radiographic data pre-treatment versus reference data revealed
forefoot pronation (metatarsal stacking angle 2.1  8.3 vs. 8.0  2.9 degrees; P = 0.002), midfoot planus
(lateral talo-ﬁrst metatarsal 28.5  15.0 vs. 13.0  7.5 degrees; P < 0.001; talocalcaneal angle 54.6  8.6 vs.
49.0  6.9 degrees; P = 0.004) and signiﬁcantly decreased calcaneus dorsiﬂexion, without hindfoot equinus
(calcaneal pitch angle 7.9  6.0 vs. 17.0  6.0 degrees; P < 0.001). After treatment, the metatarsal stacking
angle did not differ from reference values (P = 0.15). As compared with before treatment, treatment improved
mean angles for metatarsal stacking (2.1  8.3 vs. 7.1  3.9 degrees, respectively, P = 0.002), lateral talo-ﬁrst
metatarsal and talocalcaneal (both P < 0.001), with no change in the hindfoot.
Conclusion: PL may be an early target for abobotulinumtoxinA treatment in pes planovalgus associated
with premature PL activity in children with CP.
 2015 Elsevier Masson SAS. All rights reserved.
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Pes planovalgus, the most common foot deformity in cerebral
palsy (CP) [1–6], is characterized by ‘‘hindfoot and/or forefoot
valgus/pronation or midfoot break in stance or swing, with or
without equinus’’ [7]. The causes are multifactorial; 2 factors are
early muscle imbalance as a result of spasticity and overactivity of* Corresponding author. Tel.: +33 4 91 38 66 97x6905; fax: +33 4 91 49 28 31.
E-mail address: christophe.boulay@ap-hm.fr (C. Boulay).
http://dx.doi.org/10.1016/j.rehab.2015.09.001
1877-0657/ 2015 Elsevier Masson SAS. All rights reserved.peroneal muscles [5]. As the planovalgus deteriorates, more severe
foot deformities develop [5], and surgical interventions, such as
lengthening the peroneal muscle (e.g., peroneus longus [PL],
peroneus brevis), may be necessary to prevent further decline
[5,8–11].
Use of dynamic electromyography (EMG) revealed that
overactivity of the PL was the major contributing factor in spastic
planovalgus foot deformity in neurologically impaired adults with
premature onset of PL activity during the swing phase [11]. Simi-
larly, overactive PL (and gastrocnemius medialis) was demon-
strated by EMG in young children with CP (< 6 years of age) and
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contact, and planovalgus during stance [12]. EMG may be a useful
tool for early detection of abnormal muscular patterns, for early
intervention to halt or delay the progression of planovalgus.
Early botulinum toxin injection into the overactive PL may offer
clinical beneﬁts, including restoring muscle balance during growth
and preventing further progression to ﬁxed deformity. Because the
muscle must retain its ability to adapt to skeletal growth [13],
repeated injections of abobotulinumtoxinA may be of interest.
In this retrospective study, we examined injection of abobo-
tulinumtoxinA into the PL for early restoration of dynamic
muscular balance during swing, especially at initial contact, and
for enhancing stance stability in young children with hemiplegia or
diplegia, an approach not previously described. Treatment impact
was assessed by clinical and radiologic evaluation of fore-, mid-
and hindfoot positions before and after treatment. Radiologic data
were compared with reference values from children without pes
planovalgus.
2. Methods
2.1. Study design and patients
This retrospective study included children receiving treatment
at the Timone Children’s Hospital, Marseille, France, between
January 2007 and June 2010. Written informed consent was
obtained from parents at the time of treatment. According to
French law, approval by an ethics committee was not required for
the study.
Children with hemiplegia or diplegia attending the hospital
underwent a series of examinations before and after abobotuli-
numtoxinA injection. Eligibility for inclusion was determined from
medical histories. In brief, study participants were children < 6
years of age, with a diagnosis of CP by a pediatric neurologist (BC), a
Gross Motor Function Classiﬁcation System (GMFCS) level 1 or 2
(good or very good functional abilities), and equinovalgus (deﬁned
as initial contact with the hallux or head of the ﬁrst metatarsal
[M1]) conﬁrmed independently by a physical medicine and
rehabilitation physician (CB) and a physical therapist (GA).
Patients were excluded if they had a ﬁxed equinus deformity
due to a triceps surae contracture (tested passively with the
planovalgus corrected) or a limb length discrepancy > 1 cm that
could provoke a false equinus by compensation at initial contact.
EMG was used to identify premature activity of the PL.
2.2. Treatment
AbobotulinumtoxinA (Dysport1, Ipsen, Paris; 6–7 U/kg) was
injected into the PL, localized by using stimulo-detection with an
intramuscular electrode (Needle Electrodes, BiojectTM DHN 37).
The needle was introduced in the lateral side of the leg with the
same landmarks used during EMG electrode placement.
During the study period, no patients wore a serial cast or ankle-
foot orthotic, but all wore a foot plantar orthotic, which was
custom-made by the same orthotic technician, to correct
planovalgus (i.e., to mitigate forefoot pronation and hindfoot
valgus). Physiotherapy was not prescribed.
2.3. Clinical evaluation
Clinical and video observations were used to determine ankle,
and fore-, mid- and hindfoot positions at initial contact and to
conﬁrm an equinovalgus diagnosis. A posterior view at initial
contact was used to characterize both the position of the hindfoot
and the area of initial contact. Clinical examination of the plantar
side of the foot for hyperkeratosis of the M1 head and/or halluxprovided objective evidence of the preferred M1 and/or hallux
placement at initial contact. Two physicians (C.B. and G.A.)
performed a clinical bilateral goniometric assessment to assess
pre- and post-treatment angles for dorsiﬂexion of the talocrural
articulation; this assessment involved low-speed measurement of
end-range resistance with the child in the supine position with
knees ﬂexed, then extended, while ensuring no pronation of the
forefoot. These steps prevented contracture and/or spasticity of the
triceps surae. Lower-limb length (distance from anterior superior
iliac spine to medial malleolus) and foot morphology in a standing
position were assessed.
The mean number of gait cycles analyzed was 15  10. Because
previous authors have demonstrated that muscle activation depends
on speed [14–17], patients were barefoot during gait analysis so that
their walking velocity was spontaneous (rather than at an imposed
pace) and thus more easily reproduced [12,18].
2.4. EMG evaluation
Children underwent bilateral EMG examination. EMG data
were collected by using a Wiﬁ system (Zero Wire, Aurion, Italy).
EMG signals were acquired at a rate of 2000 Hz, ampliﬁed
1000 times, ﬁltered (10 Hz high-pass ﬁlter, 500 Hz low-pass ﬁlter)
and rectiﬁed to zero. This EMG technique integrates a foot-switch
system that identiﬁes the anatomic area at initial contact. A force
platform was not used.
Before positioning the electrodes, the skin was degreased,
stripped and cleaned. Two electrodes (Ag-AgCl, diameter 10 mm)
were positioned parallel to the PL ﬁbres one-quarter of the way
down the line running from the ﬁbular head to the edge of the
lateral malleolus. As recommended in the Surface EMG for the
Non-Invasive Assessment of Muscles protocol [19], electrode
centers were placed 10 mm apart and electrode positioning was
validated to minimize crosstalk between muscles (gastrocnemius
medialis and PL, and PL and tibialis anterior). Validation was
achieved by monitoring EMG activity while the patient performed
plantar ﬂexion movements with stretched knees (gastrocnemius
medialis testing), then eversion by moving the M1 downwards and
pronating the forefoot (PL testing), and ﬁnally dorsal inversion–
ﬂexion (for tibialis anterior testing). The procedure ensured
asynchronicity in the bursts of EMG activity during phases of
voluntary movement.
Premature muscle activity was determined by EMG as
described previously for the PL [12]. In brief, the onset of EMG
activity was identiﬁed by using a semi-automatic method: the
EMG signal was deﬁned as active with rectiﬁed raw signal > 20 mV
[20,21]. This threshold is commonly used for studying motor unit
potentials [20,21] and excluding artifacts. The timing of EMG
activity in the PL was analyzed and expressed as a percentage of
gait cycle (0–100%). Premature onset of PL activity was deﬁned as
EMG activity during the swing phase before initial contact (when
PL contraction does not occur in children without pes planovalgus)
[14,15]. As a convention, an activation that occurred before the
initial contact (0%) was noted as a negative value.
2.5. Radiology evaluation
A set of weight-bearing radiographs, including standard
standing lateral, dorso-plantar and anteroposterior ankle radio-
graphs, was obtained for both feet of children before and 4 to
6 months after the last abobotulinumtoxinA injection to determine
a therapeutic direct beneﬁt. The following variables were assessed:
forefoot pronation (metatarsal stacking angle), midfoot planus
(lateral talo-M1 angle and talocalcaneal angle) and hindfoot
equinovalgus (anteroposterior ankle angle for hindfoot valgus
and calcaneal pitch angle for plantar-ﬂexed hindfoot). Intra- and
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published data [22,23].
2.6. Statistical analyses
Paired t-test was used for pairwise comparisons of data from
children without pes planovalgus (reference) [22,23] and for data
for angles before and after treatment, except for the anteroposte-
rior ankle angle, for which no reference data are available for
pediatric patients. P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Patients and treatment
In total, 16 children (8 males; 3 with left hemiplegia, 7 right
hemiplegia, 6 with diplegia; mean age at ﬁrst injection
3.2  1.5 years) with PL premature activity by EMG and dynamic
equinus with hindfoot valgus received abobotulinumtoxinA (Table 1):
9 children received 1 injection, 5 children had 2 injections, 1 child had
3 injections and 1 child had 4 injections. The mean age at radiological
evaluation after treatment was 4.5  1.8 years.
3.2. Clinical evaluation
Mean pre- and post-treatment angles did not differ for
dorsiﬂexion of the talocrural articulation with both knees ﬂexed
(24.4 vs. 22.2 degrees, respectively; P = 0.19) or extended (17.2 vs.
16.6 degrees, respectively; P = 0.36) (Table 1). Treatment improved
the morphology of the fore-, mid- and hindfoot on both clinical and
video observations (Fig. 1).
3.3. Radiology evaluation
Radiology measurements in patients before treatment signiﬁ-
cantly differed from published data for children without pes
planovalgus [23]. Forefoot pronation was apparent by a signiﬁ-
cantly smaller mean metatarsal stacking angle (2.1  8.3 vs.
8.0  2.9 degrees, for patients vs. published data; P = 0.002); midfoot
planus by a signiﬁcantly larger mean lateral talo-M1 (28.5  15.0 vs.
13.0  7.5 degrees; P < 0.001) and talocalcaneal (54.6  8.6 vs.
49.0  6.9 degrees; P = 0.004) angles and plantar-ﬂexed hindfootTable 1
Clinical characteristics of study participants.
Patient No. Condition Age (years) No. injecti
Pre-treatment Post-treatment 
1 Diplegy 3 6 4 
2 Right hemiplegy 4 6.5 2 
3 Left hemiplegy 3 5 1 
4 Left hemiplegy 2 2.5 1 
5 Right hemiplegy 2 4 2 
6 Left hemiplegy 2.5 3 2 
7 Right hemiplegy 2.5 4 1 
8 Right hemiplegy 2 3 1 
9 Right hemiplegy 3 4.5 1 
10 Diplegy 7 9 2 
11 Right hemiplegy 2.5 3 1 
12 Diplegy 3.5 4.5 1 
13 Right hemiplegy 2.5 4 1 
14 Diplegy 3 4 2 
15 Diplegy 3.5 5 1 
16 Diplegy 3 4.5 3 
Mean  SD 3.2  1.5 4.5  1.8 1.6  0.9 
a 
Articulation data are angles in degrees.by a signiﬁcantly smaller mean calcaneal pitch angle (7.9  6.0 vs.
17.0  6.0 degrees; P < 0.001) (Table 2). After abobotulinumtoxinA
injection, the 2 groups did not differ in mean metatarsal stacking angle
(7.1  3.9 vs. 8.0  2.9 degrees; P = 0.15). However, treatment pro-
duced a signiﬁcantly larger mean lateral talo-M1 angle (17.6  9.7 vs.
13.0  7.5 degrees; P = 0.02) but smaller mean talocalcaneal angle
(46.7  4.8 vs. 49.0  6.9 degrees; P = 0.02). The mean calcaneal pitch
remained smaller (9.1  5.7 vs. 17.0  6.0 degrees; P < 0.001).
Comparison of pre- and post-treatment results in patients with
pes planovalgus revealed reduced forefoot pronation, as evidenced
by a signiﬁcant increase in the mean metatarsal stacking angle
(2.1  8.3 vs. 7.1  3.9 degrees for pre- vs. post-treatment; P = 0.002;
Table 2). Treatment decreased mean angles for the lateral talo-M1
(28.5  15.0 vs. 17.6  9.7 degrees; P < 0.001) and talocalcaneal
(54.6  8.6 vs. 46.7  4.8 degrees; P < 0.001), for improved midfoot
planus (Fig. 2), with no difference in calcaneal pitch and antero-
posterior ankle angles (Fig. 3). Intra- and interobserver variability was
0.5–3 and 0.6–5 degrees, respectively, comparable with previously
published values [23].
4. Discussion
This retrospective study explored whether abobotulinumto-
xinA injections into a PL showing premature EMG activity in CP
children with hemiplegia or diplegia and pes planovalgus could
improve foot morphology as seen on clinical and radiology
assessments. Clinical examination revealed no signiﬁcant diffe-
rences between mean pre- and post-treatment angles for
dorsiﬂexion of the talocrural articulation with both knees ﬂexed
or extended, for no signiﬁcant modiﬁcations of gastrosoleus
complex length after treatment. However, comparison of radiog-
raphy data for patients before treatment versus reference data for
children without planovalgus showed smaller mean metatarsal
stacking angle and larger mean lateral talo-M1 and talocalcaneal
angles as well as smaller mean calcaneal pitch angle, with no
difference after treatment compared with reference data for
metatarsal stacking angle. As compared with before treatment,
abobotulinumtoxinA injection increased the mean metatarsal
stacking angle and decreased the mean lateral talo-M1 and
talocalcaneal angles. Radiography did not reveal a change in the
hindfoot valgus as compared with the improvement seen on
clinical examination (Fig. 1). This may be explained by theons Dorsiﬂexion of talocrural articulation
Knees ﬂexed Knees extended
Pre-treatment Post-treatment Pre-treatment Post-treatment
20 30 20 20
30 35 25 25
40 20 30 15
25 10 15 10
20 30 15 20
40 20 30 15
20 25 10 15
20 15 15 10
25 15 15 15
15 10 5 5
20 20 10 15
30 35 30 35
15 20 10 15
25 20 15 15
20 20 20 15
25 30 10 20
24.4  7.5 22.2  8.0 17.2  8.0 16.6  6.8
0.19 0.36
Fig. 1. Anteroposterior views of representative children with CP who were < 6 years old with premature active PL and equinus, deﬁned as initial contact by the hallux and/or
head of the ﬁrst metatarsal. Morphology before and after abobotulinumtoxinA injection: fore- and midfoot (A vs. B) and hindfoot valgus (C vs. D) and forefoot pronation
(E vs. F).
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and midfoot and is consistent with previous ﬁndings showing
clinical hindfoot valgus equivalent to radiological calcaneus
pronation [24,25].
We found clinical improvements with abobotulinumtoxinA
treatment despite investigating children with primary deforma-
tions, which is consistent with ﬁndings in older children with CP
[2,5]. In pre-treatment radiographs, the lateral talo-M1 and
talocalcaneal angles showed a midfoot planus, which indicates
that the talus was in equinus with a hindfoot valgus. In addition,
the metatarsal stacking angle indicated forefoot pronation, which
is generally considered a more advanced deformity of planovalgus
[5]. We did not observe equinus of the calcaneus, even with a
decreased dorsi-ﬂexed hindfoot (without plantar-ﬂexed hind-
foot), which suggests that PL overactivity does not negatively
affect talocrural articulation in the pathophysiology of pes
planovalgus.Table 2
Radiology measurements of children with and without pes planovalgus pre- and post-
Angles Children with pes planovalgus
(n = 16)
Childre
planov
Pre-treatment Post-treatment 
Forefoot pronation
Metatarsal stacking angleb 2.1  8.3 7.1  3.9 8.0  2.
Midfoot planus
Lateral talo-M1 angleb 28.5  15.0 17.6  9.7 13.0  7
Talocalcaneal angleb 54.6  8.6 46.7  4.8 49.0  6
Hindfoot equinovalgus
Anteroposterior ankle anglec 14.9  4.5 13.3  2.9 –c
Calcaneal pitch angleb 7.9  6.0 9.1  5.7 17.0  6
Data are mean  SD angles in degrees.
a Paired t-test.
b Data from [22] and [23].
c Reference anteroposterior ankle measurements were not available for children witOveractivity of PL results in unlocking of the midfoot during
the swing phase [24,25]. During initial contact (Fig. 1), stress is
exerted on the unlocked midfoot, which uncovers the talus head
and causes a talus equinus resulting in a midfoot break in the
talonavicular joint [1–6]. In this study, decreasing the PL
overactivity with abobotulinumtoxinA injection reduced the
pathological process around the talonavicular joint in the
midfoot.
AbobotulinumtoxinA treatment of a PL showing premature
activity has not been previously described in young children with
CP and pes planovalgus. Successful treatment presents several
potential advantages, including delaying the age of ﬁrst, and
reducing the risk of recurrent, surgical intervention [26], improv-
ing the tolerance to orthotics and reducing foot pain during gait.
AbobotulinumtoxinA injections were administered safely and did
not provoke a crouch gait (characterized by excessive knee ﬂexion
during stance), an adverse effect that may occur with earlytreatment with abobotulinumtoxinA.
n without pes
algus (referenceb)
Pre-treatment
vs. reference
Post-treatment
vs. reference
Pre- vs.
post-treatment
P valuea P valuea P valuea
9 0.002 0.15 0.002
.5 < 0.001 0.02 < 0.001
.9 0.004 0.02 < 0.001
–c –c 0.068
.0 < 0.001 < 0.001 0.109
hout pes planovalgus.
Fig. 2. Radiographs of the midfoot of representative children showing metatarsal (A, B), lateral talo-ﬁrst metatarsal (C, D) and talocalcaneal (E, F) angles before and after
treatment.
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therapeutic beneﬁts were probably obtained by injection into just
one muscle because the children were very young (< 6 years), with
limited functional muscular abnormalities (PL and gastrocnemius
medialis), and good or very good functional abilities. Whether
abobotulinumtoxinA would have similar beneﬁts in older children
who are likely to have more limited functional abilities (GMFCS
level 3) and more extensive functional muscular abnormalities
(e.g., overactivity in other muscles such as the triceps surae and hip
muscles) would need long-term follow-up in a prospective study.Fig. 3. Radiographs of the hindfoot of representative children showing the calcaneal pitch
the hindfoot valgus (C, D) before and after treatment.As well, EMG should be used to compare the level of premature PL
activity pre- and post-treatment.
Our study contains several possible limitations. First, patients
were < 6 years old and were assessed by the GMFCS scale which is
validated for children aged 6–12 years. However, the children were
independently assessed for ambulatory function, which corrobo-
rated the functional ability score. The EMG validation procedure to
minimize crosstalk could be improved by recording the extensor
digitorum longus. Additionally, the 2 sets of radiographs were not
obtained by the same radiological therapist for all children, and the angle (A, B) for the plantar-ﬂexed hindfoot and the anteroposterior ankle angle for
C. Boulay et al. / Annals of Physical and Rehabilitation Medicine 58 (2015) 316–321 321period between radiography was variable because of the retro-
spective nature of the study. Nevertheless, the intra- and
interobserver variability was acceptable and comparable with
the literature [23]. Finally, the number of injections received
between the 2 sets of radiographs varied, with repeat injections
administered in some cases when no clinical improvement was
observed.
5. Conclusion
Prematurely active PL may be a suitable early therapeutic target
with abobotulinumtoxinA injections in patients with a dynamic
equinus and hindfoot valgus before the onset of ﬁxed planovalgus
bone deformity. Indeed, minimizing deformations such as forefoot
pronation and midfoot planus with abobotulinumtoxinA injections
into the PL may delay surgical intervention. These encouraging
results need to be conﬁrmed in prospective studies especially with
dynamic EMG (pre- versus post-injection) for quantiﬁcation of
premature active PL, evaluation of tibialis anterior paresis after
EMG normalisation and standardisation of periods between
radiography evaluation.
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